EUVIMEDEUVIMED entdecken
Crossref

Comprehensive Metabolomic Profiling in Urinary Bladder Cancer: Emerging Biomarkers for Early Diagnosis and Therapeutic Monitoring

Lalit Kumar, Niharika Gupta, Sukhad Kural, Ashish Verma, Anuja Thakur, Shefali Agarwal, Priyamvada Gupta, Harshita Tiwari, Swati Singh, Vandana Kumari, Anju Gautam, Singathala Gnana Sree und 1 weitere

ChemistrySelect · 2026-03 · 11 (10)

DOI: 10.1002/slct.202506172 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 10.03.2026. Verfasst von Lalit Kumar und 12 weiteren Autor:innen. Die Arbeit nennt 135 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urinary bladder cancer (UBCa) is a recurrent malignancy with a significant global health burden. Early and accurate detection is vital for improving outcomes. Metabolomics, the study of small molecules in biological systems, offers a powerful approach to reveal biochemical alterations in UBCa. Analysis of urine, tumor tissue, and blood highlights metabolic reprogramming, with mass spectrometry (MS) and nuclear magnetic resonance (NMR) as key profiling tools. Metabolites such as valine, tryptophan, taurine, uridine, and phosphocholine have emerged as potential biomarkers. Common alterations include reduced citrate and elevated lactic acid and fatty acids, reflecting dysregulated energy metabolism. The noninvasive nature of urine and blood sampling enhances clinical applicability. Overall, metabolomics provides valuable insights and a promising platform for early diagnosis and personalized therapy in UBCa.

Zitieren

APA

Kumar, L., Gupta, N., Kural, S., Verma, A., Thakur, A., Agarwal, S., Gupta, P., Tiwari, H., Singh, S., Kumari, V., Gautam, A., Sree, S. G., & Gautam, V. (2026). Comprehensive Metabolomic Profiling in Urinary Bladder Cancer: Emerging Biomarkers for Early Diagnosis and Therapeutic Monitoring. ChemistrySelect, 11(10). https://doi.org/10.1002/slct.202506172

Vancouver

Kumar L, Gupta N, Kural S, Verma A, Thakur A, Agarwal S, et al. Comprehensive Metabolomic Profiling in Urinary Bladder Cancer: Emerging Biomarkers for Early Diagnosis and Therapeutic Monitoring. ChemistrySelect. 2026;11(10). doi:10.1002/slct.202506172

BibTeX
@article{Kumar2026,
  author = {Kumar, Lalit and Gupta, Niharika and Kural, Sukhad and Verma, Ashish and Thakur, Anuja and Agarwal, Shefali and Gupta, Priyamvada and Tiwari, Harshita and Singh, Swati and Kumari, Vandana and Gautam, Anju and Sree, Singathala Gnana and Gautam, Vibhav},
  title = {Comprehensive Metabolomic Profiling in Urinary Bladder Cancer: Emerging Biomarkers for Early Diagnosis and Therapeutic Monitoring},
  journal = {ChemistrySelect},
  year = {2026},
  volume = {11},
  number = {10},
  doi = {10.1002/slct.202506172}
}
Kostenlos starten →